European Nod For Roche’s Ocrevus Clouded By Patient Limitation

 
• By Kevin Grogan
  
Business Keyhole
Roche's MS drug Ocrevus is close to accessing the EU market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category